146 related articles for article (PubMed ID: 18953948)
1. [The clinical and laboratory features of acute promyelocytic leukemia: an analysis of 513 cases].
Liang JY; Wu DP; Liu YJ; Ma QF; Gong JX; Zhu MQ; Xue YQ; Chen ZX
Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):389-92. PubMed ID: 18953948
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and laboratory features of patients with CD34(+) acute promyelocytic leukemia].
Liang JY; Wu DP; Liu YJ; Ma QF; Xue YQ; Zhu MQ; Chen ZX
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):196-8. PubMed ID: 19615259
[TBL] [Abstract][Full Text] [Related]
3. [Immunophenotypic features in 143 cases of acute promyelocytic leukemia].
Sun HM; Qian SX; Wu YJ; Qiao C; Hong M; Fan L; Yang H; Zhang JF; Zhang SJ; Wu HX; Qiu HX; Lu H; Xu W; Sheng RL; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):176-9. PubMed ID: 19236773
[TBL] [Abstract][Full Text] [Related]
4. CD34-positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoform.
Foley R; Soamboonsrup P; Carter RF; Benger A; Meyer R; Walker I; Wan Y; Patterson W; Orzel A; Sunisloe L; Leber B; Neame PB
Am J Hematol; 2001 May; 67(1):34-41. PubMed ID: 11279655
[TBL] [Abstract][Full Text] [Related]
5. HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia.
Oelschlaegel U; Mohr B; Schaich M; Schäkel U; Kroschinsky F; Illmer T; Ehninger G; Thiede C
Cytometry B Clin Cytom; 2009 Sep; 76(5):321-7. PubMed ID: 19291801
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
[TBL] [Abstract][Full Text] [Related]
7. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
[TBL] [Abstract][Full Text] [Related]
8. [Application of CD123 in detection of minimal residual disease in acute promyelocytic leukemia].
Wang YZ; Chang Y; Zhu HH; Qin YZ; Li JL; Fu JY; Li LD; Chen SS; Huang XJ; Lu DP; Liu YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):427-32. PubMed ID: 16800913
[TBL] [Abstract][Full Text] [Related]
9. [Combined analysis on morphology, immunology, cytogenetics and molecular biology (MICM) classification of 55 patients with acute promyelocytic leukemia].
Xiao R; Zhang R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):147-50. PubMed ID: 15157321
[TBL] [Abstract][Full Text] [Related]
10. [Immunophenotypic analysis of leukemia promyelocytes in 71 patients with acute promyelocytic leukemia].
Liu Y; Chen YT; Li JX; Zhang SH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):806-11. PubMed ID: 22931633
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis.
Lin P; Hao S; Medeiros LJ; Estey EH; Pierce SA; Wang X; Glassman AB; Bueso-Ramos C; Huh YO
Am J Clin Pathol; 2004 Mar; 121(3):402-7. PubMed ID: 15023045
[TBL] [Abstract][Full Text] [Related]
12. Acute promyelocytic leukemia: four distinct patterns by flow cytometry immunophenotyping.
Gorczyca W
Pol J Pathol; 2012 Mar; 63(1):8-17. PubMed ID: 22535601
[TBL] [Abstract][Full Text] [Related]
13. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
[TBL] [Abstract][Full Text] [Related]
15. The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes.
Albano F; Mestice A; Pannunzio A; Lanza F; Martino B; Pastore D; Ferrara F; Carluccio P; Nobile F; Castoldi G; Liso V; Specchia G
Haematologica; 2006 Mar; 91(3):311-6. PubMed ID: 16531253
[TBL] [Abstract][Full Text] [Related]
16. [Relationship of immunophenotypic features with minimal residual disease detection and gene types in 221 cases of acute promyelocytic leukemia].
Wang YZ; Qin YZ; Jiang B; Zhu HH; Chang Y; Hao L; Li JL; Li LD; Chen SS; Huang XJ; Liu YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):271-6. PubMed ID: 19379549
[TBL] [Abstract][Full Text] [Related]
17. CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint.
Biondi A; Luciano A; Bassan R; Mininni D; Specchia G; Lanzi E; Castagna S; Cantù-Rajnoldi A; Liso V; Masera G
Leukemia; 1995 Sep; 9(9):1461-6. PubMed ID: 7658712
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases.
Guglielmi C; Martelli MP; Diverio D; Fenu S; Vegna ML; Cantù-Rajnoldi A; Biondi A; Cocito MG; Del Vecchio L; Tabilio A; Avvisati G; Basso G; Lo Coco F
Br J Haematol; 1998 Sep; 102(4):1035-41. PubMed ID: 9734655
[TBL] [Abstract][Full Text] [Related]
19. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.
Paietta E; Andersen J; Gallagher R; Bennett J; Yunis J; Cassileth P; Rowe J; Wiernik PH
Leukemia; 1994 Jul; 8(7):1108-12. PubMed ID: 8035602
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR antigen-positive acute promyelocytic leukemia.
Mendoza AS; Qing X; Dungo M; Lasky J; Panosyan E; Cai J
Exp Mol Pathol; 2016 Oct; 101(2):197-200. PubMed ID: 27544027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
